Status:
COMPLETED
Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A symptomatic episode of the heart rhythm disorder 'atrial fibrillation' (AF) is a frequent reason for visits to the emergency department. Currently, in the majority of cases, immediate (electrical or...
Eligibility Criteria
Inclusion
- ECG with atrial fibrillation at the emergency department
- Heart rate \> 70bpm
- Symptoms most probable due to atrial fibrillation
- Duration of symptoms \< 36 hours
- \> 18 years of age
- Able and willing to sign informed consent
- Able and willing to use MyDiagnostick
Exclusion
- Signs of myocardial infarction on ECG
- Hemodynamic instability (systolic blood pressure \< 100mm Hg, heart rate \> 170 bpm)
- Presence of pre-excitation syndrome
- History of Sick Sinus Syndrome
- History of unexplained syncope
- History of persistent AF (episode of AF lasting more than 48 hours)
- Acute heart failure
- Currently enrolled in another clinical trial
- Deemed unsuitable for participation by attending physician
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
437 Patients enrolled
Trial Details
Trial ID
NCT02248753
Start Date
October 1 2014
End Date
December 1 2019
Last Update
January 21 2020
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
VU University Medical Center
Amsterdam, Netherlands
2
Amphia Hospital
Breda, Netherlands
3
Catharina Ziekenhuis
Eindhoven, Netherlands
4
Medisch Spectrum Twente
Enschede, Netherlands